-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lomond Therapeutics Holdings, Inc. annual/quarterly Operating Income (Loss) history and growth rate from 2022 to 2024.
- Lomond Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$11K, a 0.76% decline year-over-year.
- Lomond Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2024 was -$16.3M.
- Lomond Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$9.75M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)